HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 193 filers reported holding HAEMONETICS CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $166,324,000 | +27.0% | 4,137,423 | +14.4% | 0.03% | +14.8% |
Q3 2016 | $130,959,000 | +35.6% | 3,616,662 | +8.6% | 0.03% | +28.6% |
Q2 2016 | $96,588,000 | -14.7% | 3,331,768 | +2.9% | 0.02% | -19.2% |
Q1 2016 | $113,218,000 | +8.5% | 3,236,644 | -0.0% | 0.03% | +8.3% |
Q4 2015 | $104,395,000 | +5.5% | 3,238,043 | +5.8% | 0.02% | -7.7% |
Q3 2015 | $98,946,000 | -20.8% | 3,061,460 | +1.4% | 0.03% | -13.3% |
Q2 2015 | $124,899,000 | -9.0% | 3,019,800 | -1.1% | 0.03% | -9.1% |
Q1 2015 | $137,227,000 | +26.7% | 3,054,927 | +5.5% | 0.03% | +22.2% |
Q4 2014 | $108,312,000 | +17.3% | 2,894,502 | +9.5% | 0.03% | +3.8% |
Q3 2014 | $92,315,000 | -4.1% | 2,643,620 | -3.1% | 0.03% | -3.7% |
Q2 2014 | $96,255,000 | +2.1% | 2,728,327 | -5.7% | 0.03% | -3.6% |
Q1 2014 | $94,267,000 | -21.1% | 2,892,523 | +2.0% | 0.03% | -22.2% |
Q4 2013 | $119,525,000 | +8.4% | 2,837,060 | +2.6% | 0.04% | -2.7% |
Q3 2013 | $110,298,000 | +8.9% | 2,765,748 | +13.0% | 0.04% | 0.0% |
Q2 2013 | $101,247,000 | – | 2,448,534 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |